Riluzole - PK26124

Based on 1981 reference(s) in Google Scholar 8 10 1981

Axon 3499

CAS [1744-22-5]

MW 234.20

  • Purity: 100%
  • Soluble in 0.1N HCl(aq), DMSO, EtOH



Riluzole is a neuroprotective drug that blocks glutamatergic neurotransmission in the CNS. Riluzole inhibits the release of glutamic acid from cultured neurons, from brain slices, and from corticostriatal neurons in vivo. Riluzole also blocks some of the postsynaptic effects of glutamic acid by noncompetitive blockade of N-methyl-D-aspartate (NMDA) receptors. In vivo, riluzole has neuroprotective, anticonvulsant, and sedative properties. The hydrochloride salt form of Riluzole (Axon 3576) is available from stock as well.

KEYWORDS: Riluzole | Supplier | Glutamatergic neurotransmission blocker | PK26124 | PK 26124 | PK-26124 | CAS [1744-22-5] | [850608-87-6] | Glutamate | NMDA | Antagonist | Ion Channels | ALS | Amyotrophic lateral sclerosis

Size Unit Price Stock
50 mg €80.00 In Stock
Special Offers
Size Unit Price Stock
2 x 50 mg €120.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...